Discontinued — last reported Q4 '25
JPMorgan Chase Interest Paid decreased by 1.0% to $23.41B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $23.59B to $23.41B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 108.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.33B | $1.42B | $1.26B | $1.09B | $3.37B | $6.62B | $12.07B | $15.29B | $19.96B | $20.53B | $21.34B | $22.86B | $25.66B | $26.27B | $24.85B | $23.59B | $24.35B | $24.84B | $23.66B | $23.41B |
| QoQ Change | — | +6.5% | -11.3% | -13.7% | +209.7% | +96.4% | +82.4% | +26.7% | +30.6% | +2.8% | +4.0% | +7.1% | +12.2% | +2.4% | -5.4% | -5.1% | +3.2% | +2.0% | -4.8% | -1.0% |
| YoY Change | — | — | — | — | +152.5% | +365.7% | +857.8% | >999% | +492.5% | +210.1% | +76.8% | +49.6% | +28.5% | +28.0% | +16.4% | +3.2% | -5.1% | -5.4% | -4.8% | -0.7% |